title: Monitoring of cardiac transplants with beta 2-microglobulin, cytoimmunological monitoring and endmyocardial biopsy: what's their value in detecting rejection?
authors.affiliation: Department of Cardiovascular Surgery, University of Kiel, FRG.
authors.forename: M
authors.initials: M
authors.lastname: Semik
authors.forename: W
authors.initials: W
authors.lastname: Konertz
authors.forename: E
authors.initials: E
authors.lastname: Westphal
authors.forename: U
authors.initials: U
authors.lastname: Heusermann
authors.forename: A
authors.initials: A
authors.lastname: Friedl
authors.forename: A
authors.initials: A
authors.lastname: Bernhard
mesh_terms: D000328:Adult; D001706:Biopsy; D004699:Endocardium / Q000473:pathology*; D005260:Female; D006084:Graft Rejection; D016027:Heart Transplantation; D006801:Humans; D007958:Leukocyte Count; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged; D015166:Monitoring, Immunologic; D009206:Myocardium / Q000473:pathology*; D001613:beta 2-Microglobulin / Q000032:analysis*
chemical_list: D001613:beta 2-Microglobulin